The PKC activator PMA preconditions rabbit heart in the presence of adenosine receptor blockade: Is 5'-nucleotidase important?

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 11, 1998, Pages 2201-2211

  Iliodromitis, Efstathios K ^b   Miki, Takayuki ^a   Liu, Guang S ^a   Downey, James M ^a   Cohen, Michael V ^a,c   Kremastinos, Dimitrios T ^b  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b ONASSIS CARDIAC SURGERY CENTER   (Greece)

^c UNIVERSITY OF ALABAMA   (United States)

Author keywords

Adenosine; Chelerythrine; Phorbol ester; PKC; Preconditioning

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; CHELERYTHRINE; PHENYLEPHRINE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; THEOPHYLLINE; TRIPHENYLTETRAZOLIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HEART INFARCTION PREVENTION; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SIGNAL TRANSDUCTION; STAINING; TIME;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 18544399569     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1998.0780     Document Type: Article

References (49)

1. BROOKS G, HEARSE DJ, 1996. Role of protein kinase C in ischemic preconditioning: player or spectator? Circ Res 79: 627-630.
2. CAVE AC, HEARSE DJ, 1992. Ischaemic preconditioning and contractile function: studies with normothermic and hypothermic global ischaemia. J Mol Cell Cardiol 24: 1113-1123.
3. COHEN MV, LIU GS, DOWNEY JM, 1991. Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation 84: 341-349.
4. COHEN MV, LIU Y, LIU GS, WANG P, WEINBRENNER C, CORDIS GA, DAS DK, DOWNEY JM, 1996. Phospholipase D plays a role in ischemic preconditioning in rabbit heart. Circulation 94: 1713-1718.
5. DOWNEY JM, COHEN MV, 1997a. Arguments in favor of protein kinase C playing an important role in ischemic preconditioning. Basic Res Cardiol 92 (Suppl. 2): 37-39.
6. DOWNEY JM, COHEN MV, 1997b. Signal transduction in ischemic preconditioning. Adv Exp Med Biol 430: 39-55.
7. GOTO M, LIU Y, YANG X-M, ARDELL JL, COHEN MV, DOWNEY JM, 1995. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 77: 611-621.
8. GOTO M, COHEN MV, DOWNEY JM, 1996a. The role of protein kinase C in ischemic preconditioning. Ann NY Acad Sci 793: 177-190.
9. GOTO M, COHEN MV, VAN WYLEN DGL, DOWNEY JM, 1996b. Attenuated purine production during subsequent ischemia in preconditioned rabbit myocardium is unrelated to the mechanism of protection. J Mol Cell Cardiol 28: 447-454.
10. IKONOMIDIS JS, SHIRAI T, WEISEL RD, DERYLO B, RAO V, WHITESIDE CI, MICKLE DAG, LI R-K, 1997. Preconditioning cultured human pediatric myocytes requires adenosine and protein kinase C. Am J Physiol 272: H1220-H1230.
11. ILIODROMITIS EK, PAPADOPOULOS C, PARASKEVAIDIS IA, KYRIAKIDES ZS, FLESSA C, KREMASTINOS DT, 1996. Protection from preconditioning can be reinstated at various reperfusion intervals. Cardiovasc Drugs Ther 10: 341-346.
12. JENNINGS RB, MURRY CE, REIMER KA, 1991. Energy metabolism in preconditioned and control myocardium: effect of total ischemia. J Mol Cell Cardiol 23: 1449-1458.
13. KITAKAZE M, HORI M, TAKASHIMA S, SATO H, INOUE M, KAMADA T, 1993. Ischemic preconditioning increases adenosine release and 5́-nucleotidase activity during myocardial ischemia and reperfusion in dogs: implications for myocardial salvage. Circulation 87: 208-215.
14. 1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5́-nucleotidase activity. J Clin Invest 93: 2197-2205.
15. KITAKAZE M, HORI M, MORIOKA T, MINAMINO T, TAKASHIMA S, SATO H, SHINOZAKI Y, CHUJO M, MORI H, INOUE M, KAMADA, T, 1994b. Infarct size-limiting effect of ischemic preconditioning is blunted by inhibition of 5́-nucleotidase activity and attenuation of adenosine release. Circulation 89: 1237-1246.
16. KITAKAZE M, MINAMINO T, NODE K, KOMAMURA K, INOUE M, HORI M, KAMADA T, 1996a. Activation of ecto-5′-nucleotidase by protein kinase C attenuates irreversible cellular injury due to hypoxia and reoxygenation in rat cardiomyocytes. J Mol Cell Cardiol 28: 1945-1955.
17. KITAKAZE M, NODE K, MINAMINO T, KOMAMURA K, FUNAYA H, SHINOZAKI Y, CHUJO M, MORI H, INOUE M, HORI M, KAMADA T, 1996b. Role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5′-nucleotidase. Circulation 93: 781-791.
18. KOMAMURA K, KITAKAZE M, FUNAYA H, UEDA Y, NODE K, MINAMINO T, KURIHARA T, HORI M, 1997. Ecto-5′-nucleotidase mediates infarct size-limiting effect by ischemic preconditioning in the rabbit heart. J Cardiovasc Pharmacol 30: 775-783.
19. LI GC, VASQUEZ JA, GALLAGHER KP, LUCCHESI BR, 1990. Myocardial protection with preconditioning. Circulation 82: 609-619.
20. LI Y, KLONER RA, 1995. Does protein kinase C play a role in ischemic preconditioning in rat hearts? Am J Physiol 268: H426-H431.
21. LI Y, WHITTAKER P, KLONER RA, 1992. The transient nature of the effect of ischemic preconditioning on myocardial infarct size and ventricular arrhythmia. Am Heart J 123: 346-353.
22. 1 adenosine receptors in rabbit heart. Circulation 84: 350-356.
23. 3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart. Cardiovasc Res 28: 1057-1061.
24. LIU Y, COHEN MV, DOWNEY JM, 1994a. Chelerythrine, a highly selective protein kinase C inhibitor, blocks the antiinfarct effect of ischemic preconditioning in rabbit hearts. Cardiovasc Drugs Ther 8: 881-882.
25. LIU Y, YTREHUS K, DOWNEY JM, 1994b. Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol 26: 661-668.
26. MIKI T, MIURA T, SUZUKI K, IIMURA O, 1994. Does ectosolic-5′-nucleotidase contribute to preconditioning in the rabbit? (Abstract). Circulation 90 (Suppl. I): I-477.
27. MIKI T, COHEN MV, DOWNEY JM, 1998. Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Mol Cell Biochem 186: 3-12.
28. MURRY CE, JENNINGS RB, REIMER KA, 1986. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136.
29. MURRY CE, RICHARD VJ, JENNINGS RB, REIMER KA, 1991. Myocardial protection is lost before contractile function recovers from ischemic preconditioning. Am J Physiol 260: H796-H804.
30. NODE K, KITAKAZE M, MINAMINO T, TADA M, INOUE M, HORI M, KAMADA T, 1997. Activation of ecto-5′-nucleotidase by protein kinase C and its role in ischaemic tolerance in the canine heart. Br J Pharmacol 120: 273-281.
31. PING P, ZHANG J, QIU Y, TANG X-L, MANCHIKALAPUDI S, CAO X, BOLLI R, 1997. Ischemic preconditioning induces selective translocation of protein kinase C isoforms ε and η in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res 81: 404-414.
32. PRZYKLENK K, SUSSMAN MA, SIMKHOVICH BZ, KLONER RA, 1995. Does ischemic preconditioning trigger translocation of protein kinase C in the canine model? Circulation 92: 1546-1557.
33. PRZYKLENK K, ZHAO L, KLONER RA, ELLIOTT GT, 1996. Cardioprotection with ischemic preconditioning and MLA: role of adenosine-regulating enzymes? Am J Physiol 271: H1004-H1014.
34. 1 receptor activation is abolished by protein kinase C inhibitors in the rabbit. Cardiovasc Res 29: 682-688.
35. SCHOTT RJ, ROHMANN S, BRAUN ER, SCHAFER W, 1990. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 66: 1133-1142.
36. SHIKI K, HEARSE DJ, 1987. Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias. Am J Physiol 253: H1470-H1476.
37. SILVA PH, DILLON D, VAN WYLEN DGL, 1995. Adenosine deaminase inhibition augments interstitial adenosine but does not attenuate myocardial infarction. Cardiovasc Res 29: 616-623.
38. SPEECHLY-DICK ME, MOCANU MM, YELLON DM, 1994. Protein kinase C: its role in ischemic preconditioning in the rat. Circ Res 75: 586-590.
39. + channel? Studies of contractile function after simulated ischemia in an atrial in vitro model. Circ Res 77: 1030-1035.
40. TANG X-L, QIU Y, PARK S-W, SUN J-Z, KALYA A, BOLLI R, 1996. Time course of late preconditioning against myocardial stunning in conscious pigs. Circ Res 79: 424-434.
41. 1-Adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res 75: 576-585.
42. VAHLHAUS C, SCHULZ R, POST H, ONALLAH R, HEUSCH G, 1996. No prevention of ischemic preconditioning by the protein kinase C inhibitor staurosporine in swine. Circ Res 79: 407-414.
43. VAN WINKLE DM, THORNTON JD, DOWNEY DM, DOWNEY JM, 1991. The natural history of preconditioning: cardioprotection depends on duration of transient ischemia and time to subsequent ischemia. Coron Artery Dis 2: 613-619.
44. VAN WYLEN DGL, 1994. Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia. Circulation 89: 2283-2289.
45. VEGH A, SZEKERES L, PARRATT JR, 1990. Protective effects of preconditioning of the ischaemic myocardium involve cyclo-oxygenase products. Cardiovasc Res 24: 1020-1023.
46. YELLON DM, BAXTER GF, 1995. A "second window of protection" or delayed preconditioning phenomenon: future horizons for myocardial protection? J Mol Cell Cardiol 27: 1023-1034.
47. YELLON DM, ALKHULAIFI AM, BROWNE EE, PUGSLEY WB, 1992. Ischaemic preconditioning limits infarct size in the rat heart. Cardiovasc Res 26: 983-987.
48. YTREHUS K, LIU Y, DOWNEY JM, 1994a. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 266: H1145-H1152.
49. YTREHUS K, LIU Y, TUCHIDA A, MIURA T, LIU GS, YANG X-M, HERBERT D, COHEN MV, DOWNEY JM, 1994b. Rat and rabbit heart infarction: effects of anesthesia, perfusate, risk zone, and method of infarct sizing. Am J Physiol 267: H2383-H2390.